NCT02115373
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Please contact the Merck KGaA Communication Center located in Darmstadt, Germany
Clinical trial condition
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
NCT02115373
NCT03232593
NCT01988493
NCT02432846
NCT02205515
NCT04370860
NCT00970684
NCT05502458
NCT03419572
NCT01535053